Abstract

The Administrative Core is designed to provide administrative support for the individual research projects, the Cores and the clinical work to be conducted under the proposed Program Project. The Core also coordinates communications between the investigators in the individual Projects and Cores, organizes periodic reviews by the internal and external advisory committees of research progress and productivity, develops with consensus of principal investigators, strategic plans for the overall direction of the program, manages recruitment and allocation of needed resources, privides fiscal management support for participating investigators and prepares reports of Program progress for submission to the National Institutes of Health.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA106450-05
Application #
7847719
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
5
Fiscal Year
2009
Total Cost
$134,427
Indirect Cost

  Institution

Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065

  Publications

Kushner, Brian H; Ostrovnaya, Irina; Cheung, Irene Y et al. (2016) Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin. Oncotarget 7:4155-66
Cheung, Nai-Kong V; Cheung, Irene Y; Kramer, Kim et al. (2014) Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma. Int J Cancer 135:2199-205
Dobrenkov, Konstantin; Cheung, Nai-Kong V (2014) GD2-targeted immunotherapy and radioimmunotherapy. Semin Oncol 41:589-612
Kushner, Brian H; Modak, Shakeel; Kramer, Kim et al. (2014) Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era. Cancer 120:2050-9
O'Neill, Alison; Shah, Nilay; Zitomersky, Naamah et al. (2013) Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature. Sarcoma 2013:450478
Kushner, Brian H; Modak, Shakeel; Basu, Ellen M et al. (2013) Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody. Cancer 119:2789-95
Ahn, Eun Hyun; Mercado, Gabriela E; Laé, Marick et al. (2013) Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. Oncol Rep 30:968-78
Cheung, Nai-Kong V; Cheung, Irene Y; Kushner, Brian H et al. (2012) Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission. J Clin Oncol 30:3264-70
Tarek, Nidale; Le Luduec, Jean-Benoit; Gallagher, Meighan M et al. (2012) Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 122:3260-70
Lessnick, Stephen L; Ladanyi, Marc (2012) Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets. Annu Rev Pathol 7:145-59

Showing the most recent 10 out of 47 publications